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We thank Penela et al. for their comments and congratulate them for their achievements and 
unique work in the field. Starting in 2005, our group as well as others described the utility of 
cardiac magnetic resonance (CMR) for ventricular tachycardia (VT) substrate identification 
in the setting of structural heart disease,1–3 and the utility of CMR as an adjunct for 
electroanatomical mapping during VT ablation.4, 5 Penela et al. cite several distinctive 
manuscripts by their group that describe the technique and utility of CMR-scar integration 
for VT ablation. Notably, most did not include comparison groups without image 
integration.6–8 The most recent article cited in the Penela et al. letter does indeed compare 
acute and long-term follow-up outcomes of the 54 patients in whom the ablation was aided 
by CMR to outcomes of the remaining 105 patients.9 However, since it was published in 
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August 2017, after the submission of our manuscript on June 27, 2017,10 neither us nor the 
reviewers could have known about the work. We admire the work from the Universitat de 
Barcelona Cardiovascular Institute and look forward to future advances and novel findings 
reported by their group.
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